DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
3.440
-0.050 (-1.43%)
At close: Jul 23, 2024, 3:59 PM
3.290
-0.150 (-4.36%)
After-hours: Jul 23, 2024, 4:25 PM EDT

DiaMedica Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2016
Cash & Equivalents
2.14.544.734.717.423.97
Upgrade
Short-Term Investments
44.4248.3528.7740.4120.14
Upgrade
Cash & Cash Equivalents
46.5252.933.545.1127.527.97
Upgrade
Cash Growth
62.33%57.89%-25.74%63.94%245.43%-52.65%
Upgrade
Receivables
0.40.370.080.130.340.82
Upgrade
Other Current Assets
0.570.410.250.20.060.05
Upgrade
Total Current Assets
47.4853.6833.8445.4427.928.84
Upgrade
Property, Plant & Equipment
0.470.490.560.110.170.22
Upgrade
Long-Term Investments
1.3100000
Upgrade
Total Long-Term Assets
1.780.490.560.110.170.22
Upgrade
Total Assets
49.2654.1634.445.5528.19.05
Upgrade
Accounts Payable
0.720.930.730.511.10.18
Upgrade
Current Debt
0.090.080.070.050.070.06
Upgrade
Other Current Liabilities
1.821.781.370.970.861.08
Upgrade
Total Current Liabilities
2.622.792.171.522.031.32
Upgrade
Long-Term Debt
0.290.320.400.050.12
Upgrade
Total Long-Term Liabilities
0.290.320.400.050.12
Upgrade
Total Liabilities
2.913.12.571.532.081.44
Upgrade
Total Debt
0.380.40.470.050.120.18
Upgrade
Debt Growth
-17.21%-14.71%801.92%-55.93%-33.71%673.91%
Upgrade
Retained Earnings
-120.71-115.56-96.18-82.5-68.91-56.62
Upgrade
Comprehensive Income
-0.040.01-0.07-0.05-00
Upgrade
Shareholders' Equity
46.3551.0631.8344.0226.017.62
Upgrade
Net Cash / Debt
46.1452.533.0345.0627.47.79
Upgrade
Net Cash / Debt Growth
63.63%58.92%-26.69%64.46%251.81%-53.64%
Upgrade
Net Cash Per Share
1.221.611.252.171.750.65
Upgrade
Working Capital
44.8750.8931.6743.9225.897.52
Upgrade
Book Value Per Share
1.221.571.202.121.660.64
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).